Study of the inclusion complexes formed between 4-phenylbutyrate and α-, β- and γ-cyclodextrin in solution and evaluation on their taste-masking properties

Author:

Commey Kindness1,Nakatake Akari1,Enaka Airi1,Nishi Koji12,Tsukigawa Kenji12,Yamaguchi Koki12,Ikeda Hirohito3,Iohara Daisuke12,Hirayama Fumitoshi12,Otagiri Masaki12,Yamasaki Keishi12ORCID

Affiliation:

1. Faculty of Pharmaceutical Sciences, Sojo University , Nishi-ku, Kumamoto , Japan

2. DDS Research Institute, Sojo University , Nishi-ku, Kumamoto , Japan

3. Faculty of Pharmaceutical Sciences, Fukuoka University , Jonan-ku, Fukuoka , Japan

Abstract

Abstract Objectives 4-Phenylbutyrate (PB), which is used in the management of urea cycle disorders, has an unpleasant taste leading to poor patient compliance. Existing PB formulations though helpful, have some limitations in their use. This study reports on attempts to mask this unpleasant taste by complexing PB with cyclodextrins (CDs) to improve patient compliance. Methods α, β and γCD were used as CDs. Phase solubility studies, circular dichroism, 1H-NMR spectroscopy, including ROESY, and molecular modelling were used to investigate and characterize the PB–CD interactions in solution. The taste-masking effect of the CDs was evaluated using in vitro taste sensor measurements. Key findings PB interacts with α, β and γCD in solution to form 1:1, 1:1 and 1:2 CD: PB inclusion complexes, respectively, with stability constants in the order αCD > βCD > γCD. Taste evaluation revealed that the CDs significantly mask the taste of PB through the formation of the inclusion complexes. Notably, αCD masked the bitter taste of PB to 30% of the initial taste at a 1:1 molar ratio. Conclusion αCD significantly masks the unpleasant taste of PB in solution and can be used to formulate PB to address the limitations of existing formulations and improve patient compliance and quality of life.

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

Reference50 articles.

1. Urea cycle disorders: diagnosis, pathophysiology, and therapy;Brusilow;Adv Pediatr,1996

2. Urea cycle enzymes.;Brusilow,2001

3. Suggested guidelines for the diagnosis and management of urea cycle disorders;Häberle;Orphanet J Rare Dis,2012

4. Ammonia metabolism and hyperammonemic disorders;Walker;Adv Clin Chem,2014

5. Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation;Bachmann;Eur J Pediatr,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3